Skip to main content
. Author manuscript; available in PMC: 2016 Feb 22.
Published in final edited form as: Cell Transplant. 2013 May 22;24(1):85–95. doi: 10.3727/096368913X667736

Figure 4.

Figure 4

BM-derived c-kit+ cells decrease apoptotic cell death. (A) Lung sections stained with DAPI (blue) and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL; red) demonstrating decreased TUNEL+ cells in the lungs of hyperoxia pups treated with BM-derived c-kit+ cells. Original magnification: 200×. Scale bar: 100 μm. (B) Decreased apoptotic index in the lungs of hyperoxia pups treated with BM-derived c-kit+ cells (*p < 0.001: RA c-kit− vs. hyperoxia c-kit−, **p < 0.001: hyperoxia c-kit− vs. hyper-oxia c-kit+; n = 5–6/group). (C) Decreased CC3 protein expression in the lungs of hyperoxia pups treated with BM-derived c-kit+ cells (*p < 0.001: RA c-kit− vs. hyperoxia c-kit−, **p < 0.001: hyperoxia c-kit− vs. hyperoxia c-kit+; n = 5–6/group) demonstrated graphically and in a Western blot with β-actin as loading control.